Authors


Stanley Goldstein, MD

Latest:

Patient Education, Provider Education, and Overall Final Thoughts

In this discussion, panelists offer their final thoughts.


Sharon Hesterlee, PhD | image credit: mda.org
Sharon Hesterlee, PhD

Latest:

Building Community and Advancing Care at MDA 2025

One of the major highlights of the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference is that invaluable networking opportunities can help clinicians elevate their own best practices.


Jennifer A. Garner, PhD, RD

Latest:

Approaches for Overcoming Barriers to Cross-Sector Data Sharing

The authors identified challenges to cross-sector data sharing and the approaches used to overcome these challenges in the Mid-Ohio Farmacy, a partnership to address food insecurity.


Bridget Darby, MS

Latest:

An Evaluation of a Care Coaching and Provider Referral Intervention for Behavioral Health Needs

Care coaching and behavioral health provider referral programs produce long-term savings, reductions in avoidable utilization, and increases in targeted services to treat behavioral health conditions.


Catella Visser, RN, MSN/MBA, CCM

Latest:

Appropriate ED Utilization Leading to Better Care Coordination

Addressing avoidable emergency department (ED) utilization takes interventions in partnership with providers.


Ann Thomas, PhD

Latest:

Impact of the COVID-19 Pandemic on Regular Emergency Department Users

Regular users of the emergency department (ED) transiently reduced ED visits when faced with ED access barriers during the COVID-19 pandemic.


John W. Rowe, MD

Latest:

Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask

Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.


Joel W. Hughes, PhD

Latest:

Overdiagnosis of Adult ADHD Is Exacerbating the Stimulant Shortage

The authors argue that the stimulant shortage is being perpetuated by the overdiagnosis of attention-deficit/hyperactivity disorder (ADHD) in adults because executive functioning deficits are not included in diagnostic criteria.


Matthew Cato, MPH

Latest:

Journey to Anticoagulant Access Following Payer Rejection of Apixaban

Formulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.


Cass R. Sunstein, JD

Latest:

A “Sludge Audit” for Health System Colorectal Cancer Screening Services

A systematic, mixed methods “sludge audit” identified novel health system delivery targets for improving colorectal cancer screening services.


Dev Dash, MD, MPH

Latest:

Investigating Real-world Consequences of Biases in Commonly Used Clinical Calculators

Clinical calculators that do not include demographic variables may be biased, and their equity should be understood in the context of clinical guidelines.


Nicole Hadeed, MD

Latest:

Enhance Care Continuity Post COVID-19

Although shortfalls in continuity were well described prior to coronavirus disease 2019 (COVID-19), the pandemic has created an opportunity to augment this critical component of care delivery, with the potential to improve patient-centered outcomes and enhance spending efficiency.


Larragem Raines, MS
Larragem Raines, MS

Latest:

Contributor: The Role of Dynamic Pricing in Health Technology Assessment for MDD

Incorporating dynamic pricing into cost-effectiveness analysis could offer significant benefits for equity in health care.


Yiing-Jenq Chou, MD, PhD

Latest:

Hospital Partnership and Patient Outcomes Among Postacute Patients With Stroke

This article explores the patient-sharing relationships between acute hospitals and postacute hospitals and how these relationships influence patient discharge outcomes.


Rachel E. Barenie, PharmD, JD, MPH

Latest:

Preferences for and Experiences With Pill Appearance Changes: National Surveys of Patients and Pharmacists

Changes in generic drug appearance occur often. Patients’ and pharmacists’ responses to those changes vary, with some patients stopping their medication or using it less.


Jennifer Contreras, MPH

Latest:

Economic Burden of Nonadherence to Standards of Diabetes Care

Using propensity score matching in a US nationally representative sample, authors found the effect of nonadherence to diabetes guidelines on health care expenditures of patients with diabetes.


Stephen Thielke, MD, MS, MA

Latest:

Utilization of Low- and High-Value Health Care by Individuals With and Without Cognitive Impairment

Low-value service utilization is common among all older adults, and utilization of some high-value services decreases after the onset of cognitive decline.


Tim McDonald, MPP

Latest:

Clinic Price Reductions in a Tiered Total Cost Benefit Design

Findings of this evaluation of primary care clinic responses in a tiered total cost of care benefit design suggest that clinics respond by reducing prices.


David Strong, PhD

Latest:

Responsibility for Treating Tobacco Dependence in Health Clinics Serving Medicaid Enrollees

This article describes the implementation of Medicaid smoking cessation guidance in a large, urban federally qualified health center to examine how state-level provisions translated into clinic-level policies.



Keith C. Hemmert, MD

Latest:

An Accelerated Hospital Observation Pathway to Reduce Length of Stay for Patients With COVID-19

For select patients hospitalized due to COVID-19, an academic urban hospital implemented an observation pathway that incorporated mobile health technology, reducing hospital length of stay by more than 2 days.


Nichole Tucker

Latest:

FDA Approves Bosutinib for Pediatric Patients With CP-CML

Bosutinib has a new indication in leukemia as a well as a newly-approved formulation.


Gregory J. Norman, PhD

Latest:

Combined Effect of Continuous Glucose Monitoring and Semaglutide: Analysis of Administrative Claims

Claims data reveal larger hemoglobin A1c decreases in people with type 2 diabetes who use continuous glucose monitoring and semaglutide compared with semaglutide alone.


Shawn Kwatra, MD, FAAD

Latest:

Late-Breaking Data at AAD on Topical Ruxolitinib Show Itch Relief in Atopic Dermatitis, Prurigo Nodularis

Shawn Kwatra, MD, FAAD, physician scientist at the University of Maryland Medical System, presented data at the American Academy of Dermatology 2025 annual conference on the rapid efficacy of topical ruxolitinib for itch and inflammation, while also outlining a comprehensive approach to chronic pruritus management.


Florence X. Doo, MD

Latest:

Health Equity in the Era of Large Language Models

This article presents challenges and solutions regarding health care–focused large language models (LLMs) and summarizes key recommendations from major regulatory and governance bodies for LLM development, implementation, and maintenance.


Chethan Bachireddy, MD, MSc

Latest:

Advancing Health Equity Through Medication Formulary Policy

Medication formulary policies represent a key determinant of access to medication and can be leveraged to advance pharmacoequity and health equity writ large.


Corey Chivers, PhD

Latest:

Using Electronic Health Records and Claims Data to Identify High-risk Patients Likely to Benefit From Palliative Care

Deep learning algorithms could improve palliative care by predicting mortality from electronic health records and claims data.



Susan Chimonas, PhD

Latest:

Value-Based Management of Specialty Drugs: Practical Considerations and Implications for Pharmacy

Policy makers and health plans seek value-based management of specialty drugs. This study examines real-world factors that favor some approaches over others and their potential impact.


Vincent Lorenz, MA

Latest:

Association of Opioid Utilization Management With Prescribing and Overdose

Opioid utilization management in Medicare was associated with mixed effects on opioid prescribing, and prior authorization was associated with a decreased likelihood of subsequent overdose.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo